ESC 365 - Mr Michael Hurst

Speaker illustration

Mr Michael Hurst

Pontyclun (United Kingdom of Great Britain & Northern Ireland)

Long-term efficacy of mavacamten on health status in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy: results from long-term extension of the EXPLORER-CN trial

Event: Heart Failure 2025

Topic: Hypertrophic Cardiomyopathy

Session: ePosters in myocardial disease - hypertrophic cardiomyopathy (3)

A de novo systematic literature review to identify the clinical effectiveness and safety of different treatments for patients with non-obstructive hypertrophic cardiomyopathy

Event: Heart Failure 2025

Topic: Hypertrophic Cardiomyopathy

Session: Phenotyping in hypertrophic cardiomyopathy

Temporality of events leading to the diagnosis of obstructive hypertrophic cardiomyopathy (oHCM): a machine learning approach using UK retrospective data

Event: Heart Failure 2024

Topic: Hypertrophic Cardiomyopathy

Session: Cardiomyopathies: present and future

Long-term cardiovascular outcomes and events by New York Heart Association class in patients with obstructive hypertrophic cardiomyopathy in England

Event: Heart Failure 2023

Topic: Hypertrophic Cardiomyopathy

Session: Myocardial disease - hypertrophic cardiomyopathy 2

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources